<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="368436">
  <stage>Registered</stage>
  <submitdate>12/05/2015</submitdate>
  <approvaldate>26/05/2015</approvaldate>
  <actrnumber>ACTRN12615000525583</actrnumber>
  <trial_identification>
    <studytitle>Physiotherapists prescribing medications to manage pain in emergency departments and outpatient clinics </studytitle>
    <scientifictitle>In patients presenting to emergency departments or orthopaedic clinics with musculoskeletal conditions, does physiotherapists prescribing medications to manage pain result in adverse events?</scientifictitle>
    <utrn />
    <trialacronym />
    <secondaryid>Nil</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Musculoskeletal pain of spinal origin</healthcondition>
    <healthcondition>Peripheral musculoskeletal injuries / conditions / symptoms: sprains, strains, suspected simple fractures, subacute and chronic tendinitis, tendinosis, tenosynovitis, bursitis, tenovaginitis (trigger finger, DeQuervains) and osteoarthritic arthritic joint disease
</healthcondition>
    <conditioncode>
      <conditioncode1>Musculoskeletal</conditioncode1>
      <conditioncode2>Other muscular and skeletal disorders</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Injuries and Accidents</conditioncode1>
      <conditioncode2>Other injuries and accidents</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Physical Medicine / Rehabilitation</conditioncode1>
      <conditioncode2>Physiotherapy</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Assessment and management of patient presentation in accordance with clinical guidelines by physiotherapists in the emergency department or orthopaedic clinic.  This may involve mobilisation, massage, exercise therapy, stretches, advice and provision of the following medications, at the discretion of the physiotherapist, for the management of pain:
Paracetamol (oral tablet)
Paracetamol and Codeine (oral tablet)
Diclofenac sodium (oral tablet)
Lignocaine 1 or 2% (subcutaneous or intra-articular injection)
Nitrous Oxide up to 70% (inhaled gas)
Ibuprofen (oral tablet)
Betamethasone injection 5.7mg/ml (intra-articular injection)
Methylprednisolone acetate 40mg/ml 1ml (intra-articular injection)
Amitriptyline hydrochloride (oral tablet)</interventions>
    <comparator>Nil</comparator>
    <control>Uncontrolled</control>
    <interventioncode>Treatment: Drugs</interventioncode>
    <interventioncode>Treatment: Other</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Number of adverse events, measured as number of clinical incidents reported and related to the physiotherapist intervention</outcome>
      <timepoint>Within 1 month post intervention</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Patient satisfaction as measured on a 5 point Likert Scale</outcome>
      <timepoint>Within one week of intervention</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Staff satisfaction as measured on a 5 point Likert Scale</outcome>
      <timepoint>Within 6 months of trial commencement</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>1. Male or female aged 18 years and over
2. There is a requirement to prescribe medication to the extent necessary for the physiotherapist to practice physiotherapy,
3. Peripheral musculoskeletal injuries / conditions / symptoms: sprains, strains, suspected simple fractures, subacute and chronic tendinitis, tendinosis, tenosynovitis, bursitis, tenovaginitis (trigger finger, DeQuervains) and osteoarthritic arthritic joint disease OR Musculoskeletal pain of spinal origin
4. Ability to provide informed consent and accurately follow the instructions of the researcher 
5. Attending emergency department or outpatient clinics for the management of their musculoskeletal condition</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage />
    <inclusivemaxagetype>No limit</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>1. Open wounds
2. Infection
3. Active Inflammatory disease as the primary reason for intervention (i.e. rheumatoid disease and the seronegative arthritides)
4. Neoplastic disease as the primary reason for intervention
5. Cardiovascular disease as the primary reason for intervention
6. Metabolic disease as the primary reason for intervention
7. Central nervous system disorders as the primary reason for intervention
8. Cauda equina injury 
9. Acute head injury
10. Loss or altered state of consciousness
11. Pain of non-mechanical origin
12. Polytrauma and high energy injuries including falls from above standing height
13. Respiratory distress
14. Abdominal pain
15. Women who are pregnant and the human foetus</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Non-randomised trial</allocation>
    <concealment />
    <sequence />
    <masking />
    <assignment />
    <designfeatures />
    <endpoint />
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry>False</patientregistry>
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase />
    <anticipatedstartdate>3/08/2015</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>1200</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Not yet recruiting</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate>QLD</recruitmentstate>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Hospital</primarysponsortype>
    <primarysponsorname>QEII Jubilee Hospital</primarysponsorname>
    <primarysponsoraddress>Cnr Kessels and Troughton Roads
Coopers Plains QLD 4108</primarysponsoraddress>
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Government body</fundingtype>
      <fundingname>Department of Health (Qld)</fundingname>
      <fundingaddress>Queensland Health Building
147-163 Charlotte Street
Brisbane Queensland 4000 Australia</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname />
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>This study aims to investigate the safety and patient experience of prescribing by credentialed physiotherapists. Patients attending emergency departments and outpatient clinics with musculoskeletal conditions will be prescribed medications from a limited list to manage pain and support physiotherapy treatment.  </summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title>Dr</title>
      <name>Michael Bourke</name>
      <address>QEII Jubilee Hospital
PMB 2
Acacia Ridge QLD 4110</address>
      <phone>+61 7 3182 6238</phone>
      <fax />
      <email>michael.bourke@health.qld.gov.au</email>
      <country>Australia</country>
      <type>Principal Investigator</type>
    </contact>
    <contact>
      <title>Dr</title>
      <name>Michael Bourke</name>
      <address>QEII Jubilee Hospital
PMB 2
Acacia Ridge QLD 4110</address>
      <phone>+61 7 3182 6238</phone>
      <fax />
      <email>michael.bourke@health.qld.gov.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title>Dr</title>
      <name>Michael Bourke</name>
      <address>QEII Jubilee Hospital
PMB 2
Acacia Ridge QLD 4110</address>
      <phone>+61 7 3182 6238</phone>
      <fax />
      <email>michael.bourke@health.qld.gov.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Updating Information</type>
    </contact>
  </contacts>
</ANZCTR_Trial>